CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Henderson Molly CFO and CBO | Sale 10b5-1 | −3,439 | $7.27 | $25K | 72,576 |
| 2023-03-01 | Henderson Molly CFO and CBO | Sale | −2,032 | $8.53 | $17K | 76,015 |
| 2023-03-01 | Curran Terrie President and Chief Executive | Sale | −1,436 | $8.54 | $12K | 175,371 |
| 2023-02-13 | Parikh Asit Director | Purchase | +5,000 | $7.73 | $39K | 22,500 |
| 2023-01-20 | Curran Terrie President and Chief Executive | Sale | −5,821 | $8.20 | $48K | 176,807 |
| 2023-01-19 | Curran Terrie President and Chief Executive | Grant or award | +97,500 | 182,628 | ||
| 2023-01-19 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | ||
| 2023-01-19 | Nabulsi Azmi Chief Operating Officer | Grant or award | +45,000 | 89,567 | ||
| 2023-01-19 | Nabulsi Azmi Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-01-19 | Henderson Molly CFO and CBO | Grant or award | +33,000 | 78,047 | ||
| 2023-01-19 | Henderson Molly CFO and CBO | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2023-01-12 | Parikh Asit Director | Purchase | +5,000 | $7.00 | $35K | 17,500 |
| 2022-11-21 | Henderson Molly CFO and CBO | Sale | −2,159 | $9.60 | $21K | 43,341 |
| 2022-11-21 | Curran Terrie President and Chief Executive | Sale | −1,526 | $9.60 | $15K | 83,720 |
| 2022-09-22 | Topper James N Director | Grant or award · Stock Option (Right to Buy | +20,000 | 20,000 | ||
| 2022-09-01 | Henderson Molly CFO and CBO | Grant or award | +7,500 | 45,500 | ||
| 2022-09-01 | Curran Terrie President and Chief Executive | Grant or award | +7,500 | 85,246 | ||
| 2022-09-01 | Nabulsi Azmi Chief Operating Officer | Grant or award | +7,500 | 41,971 | ||
| 2022-05-25 | Stenhouse Mark Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-25 | Socks David A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 9 of 19 · 379 trades